Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 9,493 | 155 | 206 | 239 | 19,891 |
| Gross Profit | 9,493 | 155 | 206 | 239 | 19,891 |
| Operating Expenses | 51,179 | 65,077 | 57,661 | 49,393 | 54,223 |
| Operating Income | -41,686 | -64,922 | -57,455 | -49,154 | -34,332 |
| Interest Expense | 3,089 | 2,998 | 0 | 0 | 0 |
| Other Income | 1,368 | 1,769 | -738 | 1,085 | 660 |
| Pre-tax Income | -43,407 | -66,151 | -58,193 | -48,069 | -33,672 |
| Income Tax | 8 | 10 | 17 | 14 | -17 |
| Net Income Continuous | -43,415 | -66,161 | -58,210 | -48,083 | -33,655 |
| Net Income | $-43,415 | $-66,161 | $-58,210 | $-48,083 | $-33,655 |
| EPS Basic Total Ops | -10.64 | -16.34 | -14.54 | -11.84 | -9.00 |
| EPS Basic Continuous Ops | -10.68 | -16.30 | -14.59 | -11.90 | -9.00 |
| EPS Diluted Total Ops | -10.64 | -16.34 | -14.54 | -11.84 | -9.00 |
| EPS Diluted Continuous Ops | -10.68 | -16.30 | -14.59 | -11.90 | -9.00 |
| EBITDA(a) | $-40,101 | $-63,495 | $-56,092 | $-48,956 | $-34,038 |